Stay updated with breaking news from Naomi Eichenbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, May 11, 2023 -- Travere Therapeutics, Inc. today announced that on May 10, 2023, the Compensation Committee of its Board of Directors granted inducement equity grants to six new... | May 11, 2023
Operator: Good day, and welcome to the Travere Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call. Today's conference is being recorded.
The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with... | May 1, 2023
The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended...
SAN DIEGO, April 13, 2023 -- Travere Therapeutics, Inc. today announced that on April 10, 2023, the Compensation Committee of its Board of Directors granted inducement equity grants to five... | April 13, 2023